The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk

被引:28
|
作者
Hage, Fadi G. [1 ]
Szalai, Alexander J. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
关键词
SINGLE-NUCLEOTIDE POLYMORPHISMS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CRP GENE POLYMORPHISMS; CORONARY-HEART-DISEASE; NF-KAPPA-B; SERUM CRP; MENDELIAN RANDOMIZATION; METABOLIC-SYNDROME; TRANSGENIC MICE; PLASMA-LEVELS;
D O I
10.1007/s11883-009-0020-z
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Interest in C-reactive protein (CRP) and the association of its serum level in apparently healthy individuals to their cardiovascular disease risk has soared over the past decade. Recent studies have shown that the interindividual variations in CRP levels not only reflect environmental cues but are also a consequence of the genetic variation in the CRP gene itself. The importance of the relationship of CRP gene variants to CRP serum level and cardiovascular disease risk is important to establish CRP gene profiling as a clinical risk prediction tool and also to help test the cause-effect relationship between CRP and vascular disease. This article reviews recent studies that address the relationship of CRP gene polymorphisms to inflammation and cardiovascular risk.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 50 条
  • [41] C-reactive protein, inflammatory conditions, and cardiovascular disease risk
    Dhingra, Ravi
    Gona, Philimon
    Nam, Byung-Ho
    D'Agostino, Ralph B.
    Wilson, Peter W. F.
    Benjamin, Emelia J.
    O'Donnell, Christopher J.
    AMERICAN JOURNAL OF MEDICINE, 2007, 120 (12): : 1054 - 1062
  • [42] Obesity and normal C-reactive protein: Diminished cardiovascular risk?
    Guimaraes, JT
    Santos, AC
    Candeias, J
    Barros, H
    CLINICA CHIMICA ACTA, 2005, 355 : S324 - S324
  • [43] C-Reactive protein as cardiovascular risk factor - A discovery by ECAT
    Haverkate, F
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (10) : 1055 - 1055
  • [44] C-reactive protein as a predictor of cardiovascular risk in postmenopausal women
    Abomandor, Hala G.
    Al-Daydamony, Mohammad M.
    Shehata, Mohammad
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0H) : H9 - H9
  • [45] C-reactive protein and cardiovascular risk in the Framingham Study - In reply
    Wilson, PWF
    Pencina, M
    D'Agostino, RB
    O'Donnell, CJ
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (12) : 1328 - 1328
  • [46] Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?
    Stephan J. L. Bakker
    Ron T. Gansevoort
    Erik M. Stuveling
    Rijk O. B. Gans
    Dick de Zeeuw
    Current Hypertension Reports, 2005, 7 : 379 - 384
  • [47] High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
    Trpkovic, Andreja
    Stanimirovic, Julijana
    Resanovic, Ivana
    Otasevic, Petar
    Jevremovic, Danimir
    Djordje, Radak
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL ANALYSIS, 2015, 11 (01) : 60 - 65
  • [48] C-reactive protein and cardiovascular risk: more fuel to the fire
    Boekholdt, S. Matthijs
    Kastelein, John J. P.
    LANCET, 2010, 375 (9709): : 95 - 96
  • [49] Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?
    Bakker, SJL
    Gansevoort, RT
    Stuveling, EM
    Gans, ROB
    de Zeeuw, D
    CURRENT HYPERTENSION REPORTS, 2005, 7 (05) : 379 - 384
  • [50] Using C-reactive protein to assess cardiovascular disease risk
    Shishehbor, MH
    Bhatt, DL
    Topol, EJ
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2003, 70 (07) : 634 - 640